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The human foamy virus (HFV) contains within the UJ region of its long terminal repeat (L TR) three perfect 
consensus sequences for the binding of the inducible transcription factor AP-1. Results of DNase I footprint 
protection and gel retardation assays demonstrated that proteins in extracts of HeLa and BHK-21 cells as weil 
as bacterially expressed Jun and Fos proteins bind to these AP-1 sites. By conducting transient expression 
assays using chloramphenicol acetyltransferase plasmids carrying LTR sequences with point-mutated AP-1 
sites it was found that the three AP-1 sites contribute to the optimal activity ofthe HFV promoter. It is shown 
that lnduction of the HFV L TR by 12·0-tetradecanoylphorbol-13-acetate (TPA) and serum factors is mediated 
through the AP-1 sites. 
The human foamy virus (HFV) is a member of the third 
subfamily of exogenous retroviruses, the Spumavirinae (31). 
Molecular cloning and nucleotide sequence analysis of HFV 
have led to an increased interest in this virus groups (6, 17, 
25, 32). In addition to gag, pol and env, HFV bears three 
open reading frames, located between the env gene and the 
3' long terminal repeat (LTR), which were proposed to have 
regulatory functions (6, 18, 19). Recently, it has been dem-
onstrated that one of the three 3' open reading frames, bell, 
encodes a transcriptional transactivator (12, 26). Similar 
results have been reported for the related simian foamy virus 
type 1 (SFV-1), isolated from the rhesus macaque (21, 22). 
The transactivators offoamy viruses act at the DNA Ievel on 
a sequence in the U3 region of the viral LTR (12, 22, 26). 
The L TRs of the two sequenced foamy viruses are among 
the Iongest L TRs of the retrovirus family. U3 is 777 bp long 
in HFV and 1,296 bp long in SFV-1 (17, 21). Whereas SFV-
1 and HFV show about 80% nucleic acid similarity in the R 
and U5 regions, their U3 regions are highly divergent (17, 
21). Furthermore, littleis known about ds-acting sequences 
in the U3 regions of foamy viruses. 
In the course of studies on the HFV promoter, we noted 
three perfectly conserved binding sites for the transcrip-
tion factor AP-1 (5'-TGACTCA-3') which arenot present in 
the SFV-1 promoter (17, 21) (Fig. 1). AP-1, first isolated 
from HeLa cell extracts (2, 15), regulates the activity of a 
variety of cellular and viral genes (3, 16, 28, 29). Because of 
their responsiveness to 12-0-tetradecanoylphorbol-13-ace-
tate (TPA), the AP-1 sites are also referred to as TPA 
responsive elements (TREs) (2, 11, 14). AP-1 was shown to 
be a protein complex composed of the products of the jun 
andfos oncogene family (4). The Fos-Jun heterodimer binds 
to the TRE with high affinity, while the individual constitu-
ents of the AP-1 complex bind with a lower affinity (Jun) or 
not at all (Fos) (8, 13). 
Since the binding of AP-1 to its target sequence was shown 
to modulate the transcription of several genes, we wanted to 
know whether AP-1 or AP-1-like factors bind to the HFV 
TREs and exert an effect on the promoter activity of HFV. 
Whole cellular extracts were prepared from HeLa and baby 
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hamster kidney cells (BHK-21) as described previously (30). 
Additionally, bacterially expressed Jun and Fos proteins 
were used in DNA-protein interaction analysis. The 0.6-kbp 
Ncoi-BamHI fragment of pSVjun (1), comprising the DNA 
binding domain and the leueine zipper of v-Jun, was inserted 
into the Stui site of the bacterial expression vector pROS (5) 
in frame to the ß-galactosidase coding sequence. For the 
expression of v-Fos, a 760-bp BgUI-Ncoi fragment of 
pTZJM containing the DNA binding domain and the leueine 
zipper of v-Fos was introduced into the EcoRV site of 
pROS. The fusion proteins were purified from induced BMH 
71-18 bacteria (5) by two cycles of preparative sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis. An ex-
tract of Escherichia coli expressing c-Jun as TrpE fusion 
protein was used as described previously (1). DNase I 
footprinting reactions and gel retardation assays were per-
formed essentially as reported previously (11, 30). The 
BstEII-Hindiii (-571 to - 361) fragment of the HFV LTR 
was radioactively Iabeted at either strand and assayed with 
partially purified whole cellular extracts from HeLa and 
BHK-21 cells or with bacterially expressed v-Jun and c-Jun. 
As shown in Fig. 2, proteins from both cell types as weil as 
v-Jun and c-Jun efficiently protect the TREs of the HFV 
LTR against DNase digestion. The protected regions 
spanned about 15 nucleotides and were centered around the 
palindromic TREs but included flanking sequences as wel~. 
The binding specificity of AP-1 to the target sequences m 
the HFV L TR was further analyzed by gel retardation and 
competition assays. As shown in Fig. 3A, the band g~ner­
ated by the labeled BstEII-Hindiii fragment was shifted 
upon incubation with partially purified whole ceUular extract 
from BHK-21 cells as weil as with bacterially expressed 
c-Jun plus v-Fos. The fragment was also shifted upon 
incubation with the bacterially expressed Jun only, but the 
band appeared somewhat weaker, which might indicate the 
lower DNA binding activity ofthe Jun homodimer compared 
with that ofthe Jun-Fos heterodimer. As expected, no DNA 
bindingwas observed when the bacterially expressed v-Fos 
protein was assayed. Shifting of the labeled l!stEII-Hind~II 
fragment was abolished when the extract was mcubated wath 
a 102-fold molar excess of unlabeled fragment (specific 
competitor) or a 104 - to 105-fold molar excess of poly(dl-dC) 
(unspecific competitor). 
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s·-AACATTGACAGAGATGACiCAGGATGAAATTAGAAAAAGGTGGGAAAGTGGATATTGTGACCCCTTCAriGACTCiGGAAGTGACTCAGATGGACCCTTC-3. 
FIG. 1. Localization of the TREs within the LTR of HFV. The structure of the EcoRl-BamHI fragment of plasmid p5'LTR, spanning the 
complete 5' LTR of HFV, and the nucleotide sequence from positions -527 to -428 with respect to the start of transcription are shown. The 
start of transcription is marked by an arrow and the three TREs are marked by lines. The TATA box is marked by a bold stroke. 
Abbreviations: Af, Ajlll; B, BamHl; Bs, BstEll; E, EcoRl; H, Hindill; Ms, Mstll. 
It has been reported recently that the AP-1 binding sites in 
the visna virus L TR contribute significantly to its basal and 
transactivator-mediated activity (9). We studied the possi-
bility that the AP-1 sites in the HFV LTR play a similar 
functional role. p5'cat(-571/+325) and p5'cat(-376/+325) 
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FIG. 2. DNase footprint protection analysis of both strands of 
the BstEII-Hindiii fragment of the HFV LTR. (A) The plus strand 
was end labeled with polynucleotide kinase at the BstEII (-571) site 
of the fragment, incubated with 5 J.L8 of bacterially expressed c-Jun 
(lane 3) or v-Jun (lane 4) or with 50 J.L8 of partially purified extracts 
from HeLa cells (lane 9) or BHK-21 cells (lane 10), and subjected to 
DNase I footprinting reactions; control reactions were with 10 J.L8 
(lane 6) and 50 J.L8 (lane 7) of bovine serum albumin (BSA), no 
protein (lanes 5 and 8), 10x DNase I (lane 8), and G-specific (lane 2) 
and G+ A-specific (lane 1) sequence reactions (20). (B) The minus 
strand was end labeled with Klenow enzyme at the BstEII (-571) 
site of the fragment and incubated with 5 J.L8 of bacterially expressed 
c-Jun (lane 3) or v-Jun (lane 4) or with 50 J.L8 of partially purified 
extracts from HeLa cells (lane 5) or BHK-21 cells (lane 6); control 
reactions were without protein (lane 7) and with 10 J.L8 (lane 8) and 
50 J.Lg (lane 9) of BSA and G-specific (lane 1) and G+ A-specific (lane 
2) sequence reactions. The protected AP-1 sites are marked with 
brackets. The numbers indicate the nucleotide positions with re-
spect to the start of transcription. 
were constructed by the insertion of Bglll linkers into the 
Sau I site at position + 325 relative to the start of transcrip-
tion and into the BstEII site (position - 571) or the Ajlll site 
(position - 376). Respective Bglll fragments were then 
cloned into pOcat-Bg (27). Oligonucleotide-directed in vitro 
mutagenesis of the AP-1 binding sites was performed on the 
HFV LTR inserted into the M13mp19 vector as an EcoRI-
BamHI fragment by using the Amersham in vitro mutagen-
esis system (Amersham-Buchler, Braunschweig, Germany) 
and chemically synthesized oligonucleotides with mutated 
AP-1 sites, as shown in Table 1. Bgfll fragments of appro-
priate mutants were inserted into pOcat-Bg, giving rise to 
plasmids p5'cat-Mu1 to p5'cat-Mu6 (Table 1). The activity of 
LTR-chloramphenicol acetyltransferase (CAT) constructs 
with, without, and with point-mutated AP-1 sites was deter-
mined by transient transfections of BHK-21 cells, and sub-
sequent CAT assays were performed as described recently 
(26). As shown in Table 1 and consistent with previously 
reported results, the wild-type L TR was almost silent in 
BHK-21 cells if the cells were not cotransfected with the 
HFV-specific transactivator, bell (26). Hence, all further 
assays were performed by cotransfection of pSbell-S, a 
plasmid expressing the HFV transactivator in eukaryotic 
cells (26). Mutations of any of the three TREs (in plasmids 
p5'cat-Mu1 to p5'cat-Mu4 in Table 1) led to a decrease in 
CAT gene expression (about 25 to 30%) directed by the HFV 
L TR compared with wild-type L TR activity. A further drop 
in protein expression, to about 60% of the Ievel of the 
wild-type LTR activity, was observed when an LTR-CAT 
construct with mutations of the two downstream AP-1 sites 
(p5'cat-Mu5) was used. No further significant reduction of 
CAT activity was observed when all three TREs were either 
mutated (p5'cat-Mu6) or deleted [p5'cat(-376/+325)]. 
To show that the reduction in functional activity of the 
mutated L TR is reflected by a lower binding affinity to 
AP-1-like factors, we performed gel retardation assays. As 
shown in Fig. 3B, the mutation of any one of the AP-1 sites 
(in plasmids p5'LTRMu1 to p5'LTRMu4) led to a faster 
migration rate of the respective BstEII-Hindlll L TR frag-
ment. This was even more pronounced when a BstEII-
Hindlll LTR fragment with the two mutated downstream 
AP-1 sites (p5'LTR-Mu5) was used, and no retardationwas 
observed when all three AP-1 sites were mutated (p5'LTR-
Mu6). 
To study the influence of TPA on the gene expression 
directed by the HFV L TR, we investigated the CAT expres-
sion ofwild-type p5'cat(-571/+325), p5'cat-Mu1 (first AP-1 
site mutated), and p5'cat-Mu6 (all three AP-1 sites mutated) 
upon cotransfection with pSbell-S in the presence of dif-
ferent concentrations of TP A. As shown in Table 2, the 
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induction of wild-type L TR is stimulated threefold at a TP A 
concentration of 50 ng/ml coqtpared with induction in TPA-
free medium. At the same TPA concentration, p5'cat-Mu1 is 
stimulated about 1.7-fold, and no significant Stimulation with 
p5'cat-Mu6 was observed. When the growth factor respon-
siveness of the HFV L TR gene expression driven by the 
HFV was tested, it was found that wild-type LTR could 
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FIG. 3. Gel retardation and competition assay. (A) The end 
labeled DNA fragment was incubated with 2.5 ...,g of bacterially 
expressed v-Jun (lane 3), c-Jun (lane 4), v-Fos (lane 5), or c-Jun-v-
Fos (lane 6) or with 20 ...,g of BHK-21 cell extract (lanes 7 to 15) and 
increasing amounts of competitors and separated on a nondenatur-
ing polyacrylamide gel. The molar ratio of the labeled fragment to 
specific competitor was 1:1 (lane 8), 1:5 (lane 9), 1:20 (lane 10), or 
1:100 (lane 11). The ratio of the labeled fragment to unspecific 
competitor [poly(dl-dC)] was 1:1()2 (lane 12), 1:103 (lane 13), 1:104 
(lane 14), or 1:10' (lane 15). Control reactions were without protein 
(lane 1) or with 5 ...,g of BSA (lane 2). (B) Reaction of the 
BstEII-HindiU fragment with 2.5 ...,g of bacterially expressed v-Jun 
(lane 3), c-Jun (lane 4), v-Fos (lane 5), or v-Jun-v-Fos (lane 6) or 
with 25 ...,g of HeLa (lane 7) or BHK-21 (lanes 8 to 14) cell extract. 
Fragments with mutations, as shown in Table 1, are Mu1 (lape 9), 
Mu2 (lane 10), Mu3 (lane 11), Mu4 (lane 12), Mu5 (lane 13), and Mu6 
(lane 14). Arrows indicate free DNA. 
clearly be enhanced by increasing the serum concentration 
in the medium (Table 2). This activation was less pro-
nounced with p5'cat-Mu1 and hardly dernonstrahle with 
p5'cat-Mu6. When the three indicator plasmids were co-
transfected with pUC DNA instead ofpSbell-S at either high 
TPA or high serum concentration, only the low basal HFV 
promoter activity was observed. 
The experiments reported here show that AP-1 or an 
AP-1-like factor present in HeLa cells and BHK-21 cells 
binds to the three TREs within the HFV L TR. It is most 
likely that the binding factor in the partially purified cellular 
extracts corresponds to the transcription factor AP-1, be-
cause (i) in the DNase I footprint protection analysis (Fig. 2), 
the same prote"ction pattems were observed for the cellular 
extracts and bacterially expressed v-Jun or c-Jun protein; (ii) 
as shown by competition assays, the binding of the cellular 
factors to the AP-1 sites is specific (Fig. 3A); and (iii) this 
specific binding was further demonstrated by analyzing L TR 
fragments with mutated AP-1 sites in bandshift assays (Fig. 
38). However, the results of our experiments do not com-
pletely rule out the formal possibility that cellular factors 
other than the c-Jul'l--e-Fos complex also bind to the TREs of 
HFV. The cellular CREB protein, for example, recognizes 
both the cyclic AMP responsive element and the AP-1 target 
sequence (10, 24). The CREB binding site differs from the 
AP-1 site only in the addition of a centrat C-G base pair (7, 
24). Furthermore, it has been shown that the AP-1 site in the 
gibbon ape leukemia virus promoter is recognized by a 
T ABLE 1. Relative promoter activities of wild-type and mutated HFV LTR-CAT constructs 
Construct 
p5'cat( -571/+325)'" 
p5 'cat(-5111 + 325)d 
p5'cat-Mul'" 
p5'cat-Mu2c 
p5'cat-Mu3'" 
p5'cat-Mu4'" 
p5'cat-Mu5'" 
p5'cat-Mu6c 
p5'cat(-376/+ 325)c 
p5'cat(-376/+ 325)d 
a Mutated nucleotides are in boldface. 
Sequencea 
TGACTCA(N48)TGACTCA(N5)TGACTCA 
TGACTCA(N48)TGACTCA(N5)TGACTCA 
TGGCTCA(N48)TGACTCA(N5)TGACTCA 
TGA TfCA(N48)TGACTCA(N 5)TGACTCA 
TGACTCA(N48)TGA TfCA(N 5)TGACTCA 
TGACTCA(N48)TGACTCA(N 5)TGAA TCA 
TGACTCA(N48)TGA TfCA(N 5)TGCCTCA 
TGGCTCA(N48)TGA TfCA(N 5)TGCCTCA 
b Mean and standard deviation of six independent transfections. 
c Cotransfected with pSbell-S. 
d Cotransfected with pUC DNA. 
Relative CAT activity (%)b 
100.0 ± 0.0 
1.2 ± 0.9 
71.1 ± 4.2 
72.9 ± 2.2 
15.5 ± 2.4 
76.2 ± 3.9 
61.3 ± 1.6 
58.7 ± 1.9 
61.3 ± 2.7 
1.8 ± 1.1 
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T ABLE 2. lnduction of wild-type and mutated HFV LTR by 
TPA and serum factors 
lnduction by lnduction by fetal 
TPAa calf serumb 
Construct TPA Relative Fetal calf Relative 
concn CAT activity serum CAT activity 
(mg/ml) (%)<" (%) (%)'' 
. p5 'cat(-571/ + 325)d 0.0 100.0 ± 0.0 0.5 58.0 ± 5.0 
2.5 97.8 ± 4.4 2.5 79.4 ± 6.0 
10.0 172.0 ± 6.3 5.0 100.0 ± 0.0 
50.0 298.3 ± 5.7 10.0 106.3 ± 5.3 
p5' cat(-571/ + 325)" 50.0 2.6 ± 2.4 10.0 2.2 ± 1.6 
p5'cat-Mu1d 0.0 64.1 ± 3.7 0.5 49.4 ± 4.2 
2.5 62.3 ± 5.1 2.5 54.2 ± 3.6 
10.0 88.4 ± 4.2 5.0 52.0 ± 2.0 
50.0 104.0 ± 6.2 10.0 58.5 ± 4.2 
p5'cat-Mu1" 50.0 2.0 ± 1.9 10.0 2.6 ± 2.1 
p5'cat-Mu6J 0.0 57.6 ± 5.0 0.5 50.1 ± 3.7 
2.5 58.8 ± 3.2 2.5 52.4 ± 2.1 
10.0 53.6 ± 4.2 5.0 54.3 ± 2.6 
50.0 59.4 ± 3.8 10.0 56.2 ± 3.2 
p5'cat-Mu6" 50.0 2.9 ± 2.7 10.0 1.9 ± 1.4 
a TPA treatment was for 5 h prior to harvest of the transfected cells in 
medium containing 0.5% fetal calf serum. 
b Transfeeted cells were kept in medium containing fetal calf serum at the 
indicated concentrations for 20 h prior to harvest. 
c- Mean and standard deviation of six independent transfections. 
d Cotransfected with pSbell-S. 
.. Cotransfected with pUC DNA. 
complex unrelated to Jun or Fos protein in cerülin celllines 
(23). 
The activity of the HFV promoterwas found to depend 
mainly on the transactivator bell. However, as demon-
strated by transient transfections and subsequent CA T as-
says using constructs with mutated or deleted AP-1 sites, the 
full promoter activity is only obtained with ftinctionally 
intact AP-1 binding sites. Since constructs with defective ·or 
deleted TREs achieved approximately 60% of the wild-type 
promoter activity, it is likely that the proposed target se-
quence of the bell transactivator in the U3 region of the 
HFV LTR is not located within the BstEII-Hindlll fragment 
(-571 to - 361) harboring the AP-1 binding sites or further 
upstream. This assumption is coilsistent with recently pub-
lished data on the prelimiilary mapping of the bell target 
sequence (12). Furthermore, this result demonstrates that 
the mechanism of bell-mediated transactivation differs from 
that of visna virus, in which an AP-1 site close to the TAT A 
box seems to be one major target for the transactivator (9). 
Our experiments suggest that, as in some lentiviruses, the 
transactivator is essential for HFV replication whereas cel-
lular factors, such as AP-1, modulate viral transcription in 
response to extracellular stimuli. 
When the HFV AP-1 mutants were tested in cells grown in 
media with different serum concentrations, we also found 
the AP-1 sites tobe targets for the serum response. Similar 
results were obtained when TPA induction was analyzed. 
Responsiveness to serum factors and TP A is a known 
characteristic of AP-1 elements (2, 11, 14). As is shown for 
serum responsiveness, the induction of the HFV LTR by 
TPA seems to correlate with the copy numbers of intact 
TREs. . 
The data presented here suggest that regulation of HFV 
transcription differs from that of other retroviruses. Apart 
from the TREs and the TATA box, there are no known 
consensus sequences for transcription factors for the L TRs 
J. VIROL. 
of other retroviruses. lt is likely that other cellular factors 
whose target sequences are yet unknown contribute to the 
transcriptional regulation of HFV, implicating HFV as a 
system for further investigation of the molecular mechanism 
of retroviral gene regulation. 
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